Propranolol Starting Dose for Tachycardia
For acute management of adult supraventricular tachycardia, initiate propranolol at 0.5 to 1 mg IV over 1 minute, repeated every 2 minutes as needed up to a total dose of 0.1 mg/kg (approximately 3-5 doses). 1
Acute Intravenous Dosing for Adult Tachycardia
The 2010 American Heart Association ACLS guidelines provide clear dosing for propranolol in acute tachycardia management:
- Initial dose: 0.5 to 1 mg IV administered over 1 minute 1
- Repeat dosing: Can be repeated at 2-minute intervals if needed 1
- Maximum total dose: 0.1 mg/kg (typically 3-5 mg total for most adults) 1
Indications for use include: 1
- Stable narrow-complex tachycardias uncontrolled by adenosine or vagal maneuvers
- Rate control in atrial fibrillation or atrial flutter
- Certain polymorphic VT (associated with acute ischemia, familial LQTS, catecholaminergic)
Critical Safety Considerations
Absolute contraindications that must be excluded before administration: 1, 2
- Decompensated heart failure or cardiogenic shock
- Asthma or obstructive airway disease (risk of bronchospasm)
- Pre-excited atrial fibrillation or flutter (Wolff-Parkinson-White syndrome)
- Greater than first-degree heart block
- Hypotension
- Sinus bradycardia
Monitor closely for: 1
- Hypotension (most common adverse effect)
- Bradycardia
- Precipitation of heart failure
- Bronchospasm in susceptible patients
Oral Dosing for Chronic Management
For chronic oral therapy in adults (not acute management), the FDA-approved dosing differs significantly: 2
- Hypertension: Start 80 mg once daily (extended-release), titrate to 120-160 mg daily
- Angina: Start 80 mg once daily, average optimal dose 160 mg daily
- Migraine prophylaxis: Start 80 mg once daily, usual range 160-240 mg daily
Pediatric Considerations for SVT
In pediatric patients with supraventricular tachycardia, the approach differs substantially from adults:
- Oral maintenance therapy: 2-5 mg/kg/day divided in 2-3 doses has been used effectively 3, 4
- High-dose therapy: Doses up to 7-14 mg/kg/day (average 9 mg/kg/day) have been safely used in refractory cases 4
- Recurrence prevention: Approximately 70% of pediatric patients remain free of recurrence on propranolol 3
Important pediatric safety note: Propranolol carries risk of hypoglycemia in infants, particularly those with comorbidities, low weight, or receiving TPN 2, 5. Hypoglycemia occurred in 14.3% of infants treated for SVT, with 88.9% having comorbid conditions 5.
Common Pitfalls to Avoid
Do not use in pre-excited atrial fibrillation: Propranolol can worsen ventricular response in Wolff-Parkinson-White syndrome with atrial fibrillation 1, 2. One case report documented severe bradycardia requiring pacemaker after just 5 mg 2.
Administer slowly: The 1-minute infusion time is critical to minimize hypotension 1
Do not confuse IV and oral dosing: IV doses are measured in milligrams (0.5-1 mg), while oral doses are much higher (80+ mg) due to first-pass metabolism 2
Consider alternative agents first: Beta-1 selective agents like esmolol or metoprolol may be safer in patients with borderline contraindications, as propranolol is a nonselective beta-blocker 1
Combination therapy may be needed: In neonatal SVT, 61% required two or more medications for adequate control, suggesting monotherapy with propranolol alone may be insufficient in many cases 6